Translational investigation demonstrates LINC02323 and L1CAM promote tumor progression in lung squamous cell carcinoma, highlighting their potential as prognostic biomarkers.
Taken together, we identified that LINC02323 and its indirect target L1CAM can act as novel biomarkers for determining the prognosis of patients with LUSC and thus deserves further study.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: